Indications for renal biopsy in chronic kidney disease

Clinical Medicine

Volumn 3, Issue 6, 2003, Pages 513-517

  Tomson, Charles R V ^a  

^a SOUTHMEAD HOSPITAL   (United Kingdom)

Author keywords

Biopsy; Chronic kidney failure; Haematuria; Proteinuria

Indexed keywords

CYCLOSPORIN; CYTOTOXIC AGENT; STEROID;

CHRONIC KIDNEY DISEASE; HEMATURIA; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN PRODUCTION; KIDNEY BIOPSY; NEPHROTIC SYNDROME; PLASMAPHERESIS; PRACTICE GUIDELINE; PROGNOSIS; PROTEINURIA; REVIEW; TREATMENT INDICATION;

EID: 0346251181     PISSN: 14702118     EISSN: None     Source Type: Journal    
DOI: 10.7861/clinmedicine.3-6-513     Document Type: Review

References (14)

1. Korbet SM. Percutaneous renal biopsy. Review. Semin Nephrol 2002;22:254-67.
2. Marwah DS, Korbet SM. Timing of complications in percutaneous renal biopsy: what is the optimal period of observation? Am J Kidney Dis 1996;28:47-52.
3. Paone DB, Meyer LE. The effect of biopsy on therapy in renal disease. Arch Intern Med 1981;141:1039-41.
4. Turner MW, Hutchinson TA, Barre PE, Richard S, Jothy S. A prospective study on the impact of the renal biopsy in clinical management. Clin Nephrol 1986;26:217-21.
5. Cohen AH, Nast CC, Adler SG, Kopple JD. Clinical utility of kidney biopsies in the diagnosis and management of renal disease. Am J Nephrol 1989;9:309-15.
6. Farrington K, Levison DA, Greenwood RN, Cattell WR, Baker LR. Renal biopsy in patients with unexplained renal impairment and normal kidney size. Q J Med 1989;70:221-33.
7. Richards NT, Darby S, Howie AJ, Adu D, Michael J. Knowledge of renal histology alters patient management in over 40% of cases. Nephrol Dial Transplant 1994;9:1255-9.
8. Tomson C, Porter T. Asymptomatic microscopic or dipstick haematuria in adults: which investigations for which patients? A review of the evidence. BJU Int 2002;90: 185-98.
9. McGregor DO, Lynn KL, Bailey RR, Robson RA, Gardner J. Clinical audit of the use of renal biopsy in the management of isolated microscopic hematuria. Clin Nephrol 1998; 49:345-8.
10. Nakao N, Yoshimura A, Morita H, Takada M et al. Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial. Lancet 2003;361:117-24.
11. Feehally J. Treating IgA Nephropathy - Who, When and How? Nephron Clin Pract 2003;93:C47-8.
12. Iseki K, Iseki C, Ikemiya Y, Fukiyama K. Risk of developing end-stage renal disease in a cohort of mass screening. Kidney Int 1996;49:800-5.
13. Kasiske BL. Relationship between vascular disease and age-associated changes in the human kidney. Kidney Int 1987;31:1153-9.
14. Ball S, Cook T, Hulme B, Palmer A, Taube D. The diagnosis and racial origin of 394 patients undergoing renal biopsy: an association between Indian race and interstitial nephritis. Nephrol Dial Transplant 1997; 12:71-7.